Weidan Cao1, Xiaona Qi2, Ting Yao3, Xuanye Han4, Xujing Feng2. 1. School of Media and Communication, Temple University, Philadelphia, PA, USA. 2. Harbin Medical University Cancer Hospital, Harbin, China. 3. School of Nursing and Medical Techniques, Jianghan University, Wuhan, China. 4. The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Abstract
OBJECTIVE: The study is to examine the relationships between perceived initial cancer disclosure communication with doctors, levels of hope, and levels of trust in doctors among cancer patients in China. METHODS: A total number of 192 cancer inpatients in a cancer hospital in China were surveyed. Perceived disclosure strategies, levels of hope, levels of trust in their doctors, as well as the demographic information were obtained from the participants. RESULTS: In addition to age, patients who had higher levels of perceived emotional support from doctors, or higher levels of perceived personalized disclosure from doctors, or higher levels of perceived discussion of multiple treatment plans with doctors were more likely to have higher levels of trust in doctors. In addition to perceived health status, perceived emotional support from doctors significantly predicted participants' levels of hope. That is, patients who had higher higher levels of perceived doctors' emotional support were more likely to have higher levels of hope. Key disclosure person was a marginally significant variable, that is, patients who were mainly disclosed by family members might have higher levels of hope compared with patients who were mainly disclosed by doctors. CONCLUSIONS: When communicating with a cancer patient, doctors might not ignore the importance of emotional support during cancer diagnosis communication. Doctors might want to involve family and collaborate with family to find out ways of personalized disclosure. During the communication process, doctors could provide their patients with multiple treatment options and discuss the benefits and side effects of each treatment.
OBJECTIVE: The study is to examine the relationships between perceived initial cancer disclosure communication with doctors, levels of hope, and levels of trust in doctors among cancerpatients in China. METHODS: A total number of 192 cancer inpatients in a cancer hospital in China were surveyed. Perceived disclosure strategies, levels of hope, levels of trust in their doctors, as well as the demographic information were obtained from the participants. RESULTS: In addition to age, patients who had higher levels of perceived emotional support from doctors, or higher levels of perceived personalized disclosure from doctors, or higher levels of perceived discussion of multiple treatment plans with doctors were more likely to have higher levels of trust in doctors. In addition to perceived health status, perceived emotional support from doctors significantly predicted participants' levels of hope. That is, patients who had higher higher levels of perceived doctors' emotional support were more likely to have higher levels of hope. Key disclosure person was a marginally significant variable, that is, patients who were mainly disclosed by family members might have higher levels of hope compared with patients who were mainly disclosed by doctors. CONCLUSIONS: When communicating with a cancerpatient, doctors might not ignore the importance of emotional support during cancer diagnosis communication. Doctors might want to involve family and collaborate with family to find out ways of personalized disclosure. During the communication process, doctors could provide their patients with multiple treatment options and discuss the benefits and side effects of each treatment.
Authors: Vittorio Longo; Flavia Abruzzese; Vittoria Miserocchi; Serena Carriero; Anna Clelia Gambaro; Luca Saba; Alessandro Carriero Journal: J Public Health Res Date: 2022-03-22
Authors: Debra T Choi; Yvonne H Sada; Shubhada Sansgiry; David E Kaplan; Tamar H Taddei; Jason K Aguilar; Michael Strayhorn; Ruben Hernaez; Jessica A Davila Journal: J Gastrointest Cancer Date: 2022-06-30